Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Gross Profit (2020 - 2025)

Historic Gross Profit for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $5.7 million.

  • Maravai Lifesciences Holdings' Gross Profit fell 8245.64% to $5.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year decrease of 6831.78%. This contributed to the annual value of $108.3 million for FY2024, which is 2274.79% down from last year.
  • Per Maravai Lifesciences Holdings' latest filing, its Gross Profit stood at $5.7 million for Q3 2025, which was down 8245.64% from $7.8 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Gross Profit registered a high of $205.2 million during Q2 2022, and its lowest value of $5.7 million during Q3 2025.
  • For the 5-year period, Maravai Lifesciences Holdings' Gross Profit averaged around $86.4 million, with its median value being $39.0 million (2023).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Gross Profit surged by 60003.11% in 2021, and later tumbled by 8750.66% in 2023.
  • Quarter analysis of 5 years shows Maravai Lifesciences Holdings' Gross Profit stood at $189.3 million in 2021, then fell by 19.99% to $151.5 million in 2022, then plummeted by 74.23% to $39.0 million in 2023, then crashed by 50.32% to $19.4 million in 2024, then tumbled by 70.84% to $5.7 million in 2025.
  • Its last three reported values are $5.7 million in Q3 2025, $7.8 million for Q2 2025, and $7.7 million during Q1 2025.